In 2021, the US Food and Drug Administration (FDA) approved 50 novel drugs. Thirty-seven of the 50 (74%) novel drug approvals were reviewed and approved through an expedited review pathway, and 26 of the 50 (52%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2021.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.amjmed.2022.01.055 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!